KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Short term Debt (2016 - 2026)

Quest Diagnostics' Short term Debt history spans 18 years, with the latest figure at $503.0 million for Q1 2026.

  • On a quarterly basis, Short term Debt rose 50200.0% to $503.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $503.0 million, a 50200.0% increase, with the full-year FY2025 number at $504.0 million, down 16.28% from a year prior.
  • Short term Debt hit $503.0 million in Q1 2026 for Quest Diagnostics, roughly flat from $504.0 million in the prior quarter.
  • Over the last five years, Short term Debt for DGX hit a ceiling of $906.0 million in Q1 2024 and a floor of $1.0 million in Q1 2025.
  • Historically, Short term Debt has averaged $345.2 million across 5 years, with a median of $503.0 million in 2026.
  • Biggest five-year swings in Short term Debt: tumbled 99.89% in 2025 and later soared 50200.0% in 2026.
  • Tracing DGX's Short term Debt over 5 years: stood at $2.0 million in 2022, then skyrocketed by 15050.0% to $303.0 million in 2023, then soared by 98.68% to $602.0 million in 2024, then fell by 16.28% to $504.0 million in 2025, then dropped by 0.2% to $503.0 million in 2026.
  • Business Quant data shows Short term Debt for DGX at $503.0 million in Q1 2026, $504.0 million in Q4 2025, and $504.0 million in Q3 2025.